EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Updates to the Research Institute for Fragrance Materials, Inc. Confirmation of No Induction in Human Test Standard Protocol

Maura Lavelle iD, Isabelle Lee, Devin O'Brien, Mihwa Na, Anne Marie Api

Dermatitis® · 2025

DOI: 10.1089/derm.2025.0125 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Dermatitis®, 2025. Verfasst von Maura Lavelle und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the Research Institute for Fragrance Materials (RIFM), Mahwah, NJ, USA. Hauptthemen laut MEDLINE: Patch Tests, Odorants, Dermatitis, Allergic Contact, Cosmetics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

At the recommendation of the Expert Panel for Fragrance Safety, the Research Institute for Fragrance Materials, Inc. (RIFM) considered adopting a 48-hour challenge for confirmation of no induction in human (CNIH) studies in order to more closely mimic the patch testing conducted by dermatologists assessing allergic contact dermatitis.

Objectives

A pilot study was undertaken to ensure that adopting a new protocol would not invalidate the 30+ years of human patch-testing data collected by RIFM.

Methods

Two protocols were simultaneously tested to determine if a 48-hour challenge patching would result in reactions significantly different from those produced during a 24-hour challenge patching. RIFM tested 19 fragrance materials, including key ingredients in natural complex substances.

Conclusions

Although patching for 48 hours is more sensitive than patching for 24 hours, during this pilot, no significant differences in sensitization were noted between the two challenge protocols when 2317 subjects were tested with 19 test materials, a vehicle control, and a saline control. Therefore, adopting this new 48-hour challenge patching for RIFM-conducted CNIHs does not invalidate previously published studies conducted according to the 2008 RIFM standard protocol, which utilized a 24-hour patching during the challenge phase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patch TestsOdorantsDermatitis, Allergic ContactCosmeticsPilot ProjectsTime FactorsResearch DesignHumansMaleAdult

Substanzen

Cosmetics

Autor:innen und Institutionen

  • From the Research Institute for Fragrance Materials (RIFM), Mahwah, NJ, USA.
  • Estee Lauder Companies, Melville, NY, USA.

ORCID-Profile: Maura Lavelle

Zitieren

APA

Lavelle, M., Lee, I., O'Brien, D., Na, M., & Api, A. M. (2025). Updates to the Research Institute for Fragrance Materials, Inc. Confirmation of No Induction in Human Test Standard Protocol. Dermatitis®. https://doi.org/10.1089/derm.2025.0125

Vancouver

Lavelle M, Lee I, O'Brien D, Na M, Api AM. Updates to the Research Institute for Fragrance Materials, Inc. Confirmation of No Induction in Human Test Standard Protocol. Dermatitis®. 2025. doi:10.1089/derm.2025.0125

BibTeX
@article{Lavelle2025,
  author = {Lavelle, Maura and Lee, Isabelle and O'Brien, Devin and Na, Mihwa and Api, Anne Marie},
  title = {Updates to the Research Institute for Fragrance Materials, Inc. Confirmation of No Induction in Human Test Standard Protocol},
  journal = {Dermatitis®},
  year = {2025},
  doi = {10.1089/derm.2025.0125}
}
Kostenlos starten →